Table 1 Correlation between clinicopathological features and RGC32 expression.
From: RGC32 induces epithelial-mesenchymal transition by activating the Smad/Sip1 signaling pathway in CRC
Characteristics | Low, n (%) | High, n (%) | χ2 value | P value |
|---|---|---|---|---|
Frequency (%) | 13 (7.7) | 170 (92.3) | Â | Â |
Sex, n (%) | ||||
 Male | 46 (42.2) | 63 (57.8) | 0.251 | 0.616 |
 Female | 34 (45.9) | 40 (54.1) |  |  |
Age, n (%) | ||||
 <50 | 59 (43.1) | 78 (56.9) | 0.094 | 0.76 |
 ≥50 |  |  |  |  |
Tumor size (diameter in cm) | ||||
 <5 | 39 (39.8) | 59 (60.2) | 0.225 | 0.636 |
 ≥5 | 41 (43.2) | 54 (56.8) |  |  |
Tumor differentiation | ||||
 Good | 24 (40.0) | 36 (60.0) | 0.525 | 0.769 |
 Moderate | 40 (46.0) | 47 (54.0) |  |  |
 Poor | 16 (44.4) | 20 (55.6) |  |  |
Depth of tumor invasion | ||||
 Subserosa | 7 (41.2) | 10 (58.8) | 4.932 | 0.085 |
 Serosa | 34 (37.0) | 58 (63.0) |  |  |
 Adjacent organs | 40 (54.1) | 34 (47.3) |  |  |
Lymph node status | ||||
 Negative | 39 (52.7) | 35 (47.3) | 4.078 | 0.043 |
 Positive | 41 (24.4) | 68 (75.6) |  |  |
Dukes classification | ||||
 A+B | 42 (38.9) | 66 (61.1) | 4.446 | 0.035 |
 C+D | 41 (54.7) | 34 (45.3) |  |  |
TNM stage | ||||
 stage I+II | 41 (37.3) | 69 (62.7) | 3.908 | 0.048 |
 stage III+IV | 38 (52.1) | 35 (47.9) |  |  |
